Welcome to Coulter Partners Global (English)

18 October 2021

Top hires for VC & PE portfolio companies Q3-2021

Search Highlights

Recent top global hires for Venture Capital and Private Equity backed companies, covering a broad range of disciplines and sectors across Life Sciences, Health, and Tech.

This quarter’s successful placements include:

Function Focus area Location
CEO Oncology US
Chief Operating Officer A.I. for drug discovery UK
Chief Medical Officer Autoimmune disorders UK
Chief Scientific Officer Metabolomics technology US
Chief Business Officer Immunotherapies Switzerland
Chief Technology Officer Life science tools US
SVP Pharma Strategy & Growth Digital health UK
VP R&D CNS gene therapies US
VP Clinical Development Oncology & vaccines UK
VP Chemistry RNA therapeutics US
Head of Sales & Marketing Medical devices Germany
Head of Preclinical Immune-oncology UK
Country Manager UK DNA-based diagnostics Sweden
Scientific Affairs Director Contract manufacturing France
Board Director Oncology and autoimmune diseases France
Partner Life sciences venture capital Netherlands

Newly opened projects include:

Function Focus area Location
Chief Financial Officer COVID-19 therapeutics UK
Chief Commercial Officer Digital pathology France
Chief Medical Officer Oncology and rare diseases UK
Chief Operating Officer Digital (mental) health Germany
Country CFO Veterinary services Norway
VP Clinical Development CNS gene therapy US
VP CMC Precision biotherapeutics Singapore
Head of Commercial Digital therapeutics US
Head of Regulatory Affairs Gene therapy US
Global Director Medical & Scientific Affairs Wound care UK
2x Board Director Autoimmunology disorders Denmark
Chair Drug discovery services UK
Partner Life science venture capital Canada


A new version of Coulter Partners is available.